Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beaver Lake Advisors is a private advisory and consulting firm rather than a drug development or healthcare operating company. Publicly available information indicates it was formed in 2018 and is an active New York limited liability company. The firm appears to provide industry and transaction advisory services, including work for private equity funds, and is associated publicly with principal Kevin Hobert, a medtech executive. Based on available evidence, Beaver Lake Advisors does not appear to own a therapeutic pipeline, develop drugs, or operate as a biotech, pharma, or healthcare services company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beaver Lake Advisors.